Hematological Malignancies
Showing NaN - NaN of 5
Hematological Malignancies Trial in Worldwide (Pembrolizumab/vibostolimab coformuation)
Recruiting
- Hematological Malignancies
- Pembrolizumab/vibostolimab coformuation
-
Duarte, California
- +64 more
Jan 27, 2023
Hematological Malignancies Trial in United Kingdom, United States (Magrolimab, Azacitidine)
Active, not recruiting
- Hematological Malignancies
- Magrolimab
- Azacitidine
-
Duarte, California
- +26 more
Dec 7, 2022